Venditti; Charles P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Venditti; Charles P..The latest application filed is for "synthetic genes for the treatment of propionic acidemia caused by mutations in propionyl-coa carboxylase alpha".

Company Profile

8.9.16

Venditti; Charles P. - Potomac MD
Venditti; Charles P. - Bethesda MD
Venditti; Charles P. - Kensington MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
AAV with unique capsid protein VP1 and methods of using for treatment Grant 11,447,797 - Chiorini , et al. September 20, 2	2022-09-20
Synthetic Genes For The Treatment Of Propionic Acidemia Caused By Mutations In Propionyl-coa Carboxylase Alpha App 20220251536 - Venditti; Charles P. ; et al.	2022-08-11
Non-disruptive Gene Therapy For The Treatment Of Mma App 20220218843 - Venditti; Charles P. ; et al.	2022-07-14
Biomarkers of organic acidemias Grant 11,372,004 - Venditti , et al. June 28, 2	2022-06-28
Viral Gene Therapy As Treatment For Cholesterol Storage Disease Or Disorder App 20210113635 - Venditti; Charles P. ; et al.	2021-04-22
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA) Grant 10,894,077 - Venditti , et al. January 19, 2	2021-01-19
Codon-optimized Human Npc1 Genes For The Treatment Of Niemann-pick Type C1 Deficiency And Related Conditions App 20200377906 - Venditti; Charles P. ; et al.	2020-12-03
Isotopic Biomarkers Of Organic Acidemias App 20200345268 - VENDITTI; Charles P. ; et al.	2020-11-05
Biomarkers Of Organic Acidemias App 20200217856 - VENDITTI; Charles P. ; et al.	2020-07-09
Synthetic Methylmalonyl-coa Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (mma) App 20190298814 - VENDITTI; Charles P. ; et al.	2019-10-03
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA) Grant 10,307,469 - Venditti , et al.	2019-06-04
Gene Therapy For Combined Methylmalonic Acidemia/aciduria And Hyperhomocysteinemia/homocystinuria, Cobalamin C Type, And Deficiency Of Mmachc App 20180353623 - Venditti; Charles P. ; et al.	2018-12-13
Viral Gene Therapy As Treatment For Cholesterol Storage Disease Or Disorder App 20180104289 - Venditti; Charles P. ; et al.	2018-04-19
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA) Grant 9,944,918 - Venditti , et al. April 17, 2	2018-04-17
Tagged Form Of Mut Enzyme, Genetic Constructs Incorporating It, And Its Use In Gene Thereapy App 20180087041 - Venditti; Charles P.	2018-03-29
Synthetic Methylmalonyl-coa Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (mma) App 20170326212 - VENDITTI; Charles P. ; et al.	2017-11-16
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA) Grant 9,719,080 - Venditti , et al. August 1, 2	2017-08-01
Synthetic Methylmalonyl-coa Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (mma) App 20170067042 - VENDITTI; Charles P. ; et al.	2017-03-09
Synthetic Methylmalonyl-coa Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (mma) App 20160040150 - VENDITTI; Charles P. ; et al.	2016-02-11
Method for direct measurement of isotopes of expired gases Grant 8,721,988 - Venditti May 13, 2	2014-05-13
Device And Method For Direct Measurement Of Isotopes Of Expired Gases App 20130009054 - Venditti; Charles P. ; et al.	2013-01-10
Device and method for direct measurement of isotopes of expired gases Grant 8,293,187 - Venditti , et al. October 23, 2	2012-10-23
Device And Method For Direct Measurement Of Isotopes Of Expired Gases App 20100252732 - Venditti; Charles P. ; et al.	2010-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.